US 8969370
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
granted A61KA61K31/197A61K31/485
Quick answer
US patent 8969370 (3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists) held by Theravance Biopharma R&D IP, LLC expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/197, A61K31/485, A61K45/06, A61K47/02